Articles of Lung-cancer vaccine

The final results of the study confirming the effectiveness of CIMAvax-EGF in advanced lung cancer will be presented at an international workshop to be held in Havana on May 12-13. The implementation of the vaccine-conceived by experts of the Center for Molecular Immunology (CIM)- in primary health care, its overall safety profile and post-registration experiences in other countries, will also be discussed at the V International Workshop on the subject, to be held at Havana’s Conference Center.